
    
      PROTOCOL OUTLINE: This is a randomized, double blind, cross over study. Patients are
      randomized to start with one of two different doses of sodium dichloroacetate (DCA).

      Patients receive one of two doses of oral DCA for 6 months, then switch to the alternate dose
      for 6 months. This course is repeated once.

      Patients are followed for up to 2 years.

      Completion date provided represents the completion date of the grant per OOPD records
    
  